AngioDynamics ANGO Cash Flow Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| -$31.39M+24.2% | -$27.71M+87.7% | -$32.1M+86.8% | -$33.99M+81.6% | -$41.39M+78.5% | ||
| $23.19M-13.4% | $23.92M-14.5% | $25.04M-10.0% | $25.8M-6.9% | $26.78M-5.9% | ||
| $11.69M+16.5% | $11.4M+11.3% | $11.04M+15.1% | $9.77M-7.2% | $10.03M-13.7% | ||
| —— | —— | —— | —— | —— | ||
| $2.95M-30.8% | $3.73M+21.8% | $4.1M+45.5% | $4.46M+77.3% | $4.25M+41.4% | ||
| -$7.3M— | -$8.98M— | -$9.32M— | -$10.18M— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $397K+107% | -$255K+99.6% | $515K+101% | ||
| —— | —— | —— | —— | -$31.3M-165% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does AngioDynamics generate?
- AngioDynamics (ANGO) generated -$50.4M in operating cash flow over the trailing twelve months.
- What is AngioDynamics's free cash flow?
- After $2.9M of capital expenditures, AngioDynamics's free cash flow was -$55.1M over the trailing twelve months, up 26.8% year over year.
- Where does AngioDynamics's cash flow data come from?
- Every line is extracted from AngioDynamics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
